CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
91 hedge funds and large institutions have $103M invested in Concert Pharmaceuticals, Inc. in 2021 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
66% less capital invested
Capital invested by funds: $301M → $103M (-$198M)
Holders
91
Holding in Top 10
–
Calls
$604K
Puts
$242K
Top Buyers
| 1 | +$6.04M | |
| 2 | +$2.15M | |
| 3 | +$1.73M | |
| 4 |
SPIA
Steward Partners Investment Advisory
New York
|
+$1.73M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$784K |
Top Sellers
| 1 | -$14.6M | |
| 2 | -$11.3M | |
| 3 | -$8.6M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$6.79M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.85M |